Open AccessAbstract 5874: Cdk4/6 kinase inhibitor resistance in prostate cancer
Author(s) -
Renée de Leeuw,
Matthew J. Schiewer,
Christopher McNair,
Michael A. Augello,
Akihiro Yoshida,
E. Starr Hazard,
Sean M. Courtney,
Gerard T. Hardiman,
Justin M. Drake,
Felix Y. Feng,
Scott A. Tomlins,
Maha Hussain,
J. Alan Diehl,
William Kevin Kelly,
Karen E. Knudsen
Publication year - 2017
Publication title -
cancer research
Language(s) - Uncategorized
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2017-5874
Subject(s) - palbociclib , prostate cancer , cancer research , medicine , cyclin dependent kinase 4 , retinoblastoma protein , kinase , androgen receptor , cancer , drug resistance , cell cycle , oncology , pharmacology , biology , breast cancer , cyclin dependent kinase 2 , microbiology and biotechnology , genetics , metastatic breast cancer